Health Care/Hospital

Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)

80% of Methylated Patients and 75% of Unmethylated Patients Were Disease Progression-Free at 6 Months PLYMOUTH MEETING, Pennsylvania, Nov. 5, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today positive interim results from Inovio's Phase 2 study (NCT03491683) of newl...

2019-11-05 21:00 887

Canadian Brand, PureForm Pet Health Supplements, First to Launch Earth-Friendly Packaging

CHILLIWACK, British Columbia, Nov. 5, 2019 /PRNewswire/ -- PureForm Pet Health Supplements, based inChilliwack, BC, was the first in their industry to introduce biodegradable canisters and compostable shipping materials.

2019-11-05 21:00 341

Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute

- Start-up companies ImagoWorks and Sibel recognized for novel health tech solutions that harness artificial intelligence, geometrical modeling and bio-integrated sensors aiming to improve the detection, prevention and and treatment of diseases SEOUL, South Korea, Nov. 5, 2019 /PRNewswire/ -- Ja...

2019-11-05 13:00 1114

Cognate BioServices announces acquisition of Cobra Biologics

- Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial products - EW Healthcare Partners and its co-investors provide the financing for the transaction MEMPHIS, Tennessee, Nov. 5, 2019 /PRNewswire/ -- Cognate BioServices...

2019-11-05 12:32 400

Farrer Park Hospital Introduces High Intensity Focused Ultrasound (HIFU) Treatment for Uterine Fibroid in Singapore

SINGAPORE, Nov. 5, 2019 /PRNewswire/ -- Farrer Park Hosiptal (FPH) introduces High Intensity Focused Ultrasound (HIFU) inSingapore. HIFU is a new technology for the treatment of uterine fibroids, adenomyoma, adenomyosis. It is a non-invasive surgery that uses focused ultrasound to generate hig...

2019-11-05 09:00 332

"Live bacteria" soil health and animal nutrition firm Terragen Holdings Ltd launches $20m IPO

* Australian agricultural microbial products company Terragen Holdings Ltd launches a$20 million initial public offer (IPO) of shares, comprising 80 million shares at25 cents per share * Terragen has developed and commercialised a range of biological products that use live microbes to address...

2019-11-05 06:10 472

Health Charities Benefit from Nationwide Fundraising Campaign

SYDNEY, Nov. 5, 2019 /PRNewswire/ -- AFT Pharmaceuticals is getting behind three charities in a bid to help them raise vital funding for vulnerable Aussies - and get people talking about health. The company's founder and CEO, Hartley Atkinson says the initiative is an opportunity to give back to...

2019-11-05 05:30 447

Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance®

- Alliance to focus combined expertise and investment to maximise Jardiance® for people with type 2 diabetes, heart failure, and chronic kidney disease - Alliance to continue to include three product families – empagliflozin, linagliptin and insulin glargine INGELHEIM, Germany, and INDIANAPOLIS,...

2019-11-04 22:00 2880

Seoul National University Bundang Hospital Achieves Global Healthcare Accreditation

PALM BEACH GARDENS, Florida, Nov. 4, 2019 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) (https://www.snubh.org/dh/en/) in Seoul, South Korea has been awarded a three-year term of accreditation by the Global Healthcare Accreditation (GHA) Program ( http://globalhealthcareaccre...

2019-11-04 21:00 447

Ossur and Alfred Mann Foundation Sign New Agreement to Extend Exploration of Mind-Controlled Prosthetics

REYKJAVIK, Iceland and SANTA CLARITA, CA, Nov. 4, 2019 /PRNewswire/ -- Jon Sigurdsson, President & CEO of Ossur and John Petrovich, CEO of the Alfred Mann Foundation (AMF) recently signed a milestone agreement that allows Ossur to further develop and license AMF's implanted myoelectric sensor (IM...

2019-11-04 15:37 2490

Picosun Expands Selection of Biocompatible ALD Materials for Medical Applications

ESPOO, Finland, Nov. 4, 2019 /PRNewswire/ -- Picosun Group, the leading supplier of AGILE ALD® (Atomic Layer Deposition) thin film coating solutions for global industries, expands its selection of biocompatible ALD materials to be used in medical applications. Picosun's TiO2 and Al2O3 processes ...

2019-11-04 13:00 361

Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease

* Oligomannate, A New Oral Treatment For Mild To Moderate Alzheimer's Disease * The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- Shanghai Green Valley Pharmaceuticals (Green Valley) today announced thatChina's National Medical Products Administrat...

2019-11-04 10:30 518

IEV Holdings Limited expands into postpartum care through acquisition of Lady Paradise

SINGAPORE, Nov. 4, 2019 /PRNewswire/ -- The demand for post-natal care in Asia is on the rise with an increasing number of mothers from countries likeChina, Japan and Malaysia turning to post-partum care centers after the birth of their children. Eyeing up this growth,Singapore-based investment h...

2019-11-04 09:00 485

Healthcare Support Remains Strong For Singaporeans With Advanced Breast Cancer, But Patients Call For Greater Disease Education, Survey Finds

* The survey aims to better understand the lives of women living with advanced breast cancer and seeks to provide support to these women around the globe.[1] * With new and better treatments, patients with advanced breast cancer are now living longer and better than before SINGAPORE, Nov. 4, ...

2019-11-04 08:15 464

ClinicAll Enters Cooperation Partnership With The Private Office of Sheikh Saeed Bin Ahmed Al Maktoum and SEED Group

NEW YORK, Nov. 3, 2019 /PRNewswire/ -- ClinicAll International Corporation is excited to announce the strategic partnership withThe Private Office of Sheikh Saeed Bin Ahmed Al Maktoum and SEED Group. New partnership between T...

2019-11-03 19:30 784

Medical Tourism Conference Enjoys Record Success after Relocation to Abu Dhabi

PALM BEACH GARDENS, Florida, Nov. 1, 2019 /PRNewswire/ --The Medical Tourism Association has successfully hosted its 12th World Medical Tourism & Global Healthcare Congress (WMTC) inAbu Dhabi since moving the event overseas for the first time. This year's 12th annual WMTC, took place from Oct....

2019-11-01 23:38 1138

Encore Medical Education Will Publish the Official Best of SABCS(R) News From the 2019 San Antonio Breast Cancer Symposium (SABCS(R)) Starting December 12, 2019

SAN ANTONIO, Texas, Nov. 1, 2019 /PRNewswire/ -- Encore Medical Education ( www.encoremeded.com ) will publish the Official SABCS® News highlighting the key findings presented at the 42nd San Antonio Breast Cancer Symposium (SABCS®), held on December 10-14, 2019 in San...

2019-11-01 23:00 1149

High Performance Swine Production With Reduced Use of Antibiotics: Second Workshop by EW Nutrition and OPP Group

From 4 to 7 November, in Lleida, Spain, OPP Group and EW Nutrition are hosting their second workshop on animal health and welfare with reduced antibiotic use LLEIDA, Spain, Nov. 1, 2019 /PRNewswire/ -- The two-day event offers swine producers and other stakeholders essential, actionable informati...

2019-11-01 20:22 1123

Seneca Biopharma and Jiangsu QYuns Therapeutics Announce Development Plan for Potential Joint Pipeline at 7th China Renaissance Healthcare and Life Science Leadership Summit

GERMANTOWN, Maryland, Nov. 1, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (NASDAQ: SCNA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., aChina-based company focused on monoclonal antibody thera...

2019-11-01 19:00 585

AXA Hong Kong and Macau hosts its first 'Hack for Health' challenge to explore innovations for health protection

HONG KONG, Nov. 1, 2019 /PRNewswire/ -- AXA Hong Kong and Macau successfully completed its first Health Data Hackathon, "Hack For Health" ("the Hackathon"), from 18-20 October 2019 at the Microsoft office in Cyberport. The Hackathon attracted close to 100 participants in 19 teams from more than 10...

2019-11-01 12:06 919
1234567 ... 228